E-course: Challenging bladder cancer cases: A multidisciplinary tumour board perspective
This e-course provides practical case-based guidance to harmonised clinical practice, and enhances the quality and consistency of patient care.
Management of bladder cancer increasingly requires multidisciplinary alignment as therapeutic complexity grows. Emerging immunotherapy and intravesical therapies; integration of biomarkers such as circulating tumour DNA (ctDNA) for adjuvant decision-making; persistent variability in the timing of radical cystectomy and radiotherapy, underscore this need.
| Organiser | European School of Urology (ESU) |
|---|---|
| CME | 1.00 |
| Duration | Approx. 60 minutes |
Through an examination of 3 challenging bladder cancer cases, this e-course will address the following challenges:
- Uncertainty in sequencing emerging bladder-sparing options
- Under-utilisation of radiotherapy in multimodal treatment
- Delayed referral for radical cystectomy
- Variation in pathology interpretation and reporting
- Hesitation around early adoption of ctDNA-guided decision-making
- Fragmented communication in centres lacking a structured multidisciplinary team.
Speakers:
- Dr. L.S. Mertens (NL)
- Dr. M.C. Mir Maresma (US)
- Dr. G. Marcq (FR)
- Dr. O. Rodriguez Faba (ES)
- Ass. Prof. M. Eckstein (DE)
- Dr. M. Pecoraro (IT)
- Dr. S. Gupta (US)
- Dr. V. Achard (FR)
This e-course is brought to you in collaboration with the EAU Sections of Urological Imaging and Oncological Urology.